Gülseren YÜCESOY, Nadi KESKİN, Birol VURAL, Semih ÖZEREN, Aydın ÇORAKÇI, Leyla EREN, Ahmet ERK, İzzet YÜCESOY

Myoma Uteri Olgularında Risk Faktörleri ve Operasyon Endikasyonlarının İncelenmesi

Myoma uteri nedeniyle opere edilen 30 olgu risk faktörleri ve operasyon endikasyonları yönünden retrospektif olarak incelenmiştir. Sağlıklı 30 kadın kontrol grubunu oluşturmuştur. Obesite, sigara kullanımı, aile anamnezi her iki grupta farklılık göstermemiştir (p>0,005). Myom olgularında, kontrol grubuna göre doğum sayısı fazla ve eğitim düzeyi düşük ve buna bağlı olarak toplam emzirme süresi istatistiksel anlamlı derecede uzun bulunmuştur (p

Anahtar Kelimeler:

Myoma, uteri, cerrahi

The Analysis Operation Indications and Risk Factors in Uterine Myomas Cases

Thirty cases operated with the diagnosis of uterine myomas have been investigated from the view point of risk factors and operation indications. The control group is composed of thirty healthy women. In terms of obesity, smoking, family history of uterine myoma there were no difference between two groups. In myoma cases there were more parturitions and lower education levels and consequently the period of lactation was found statistically longer than the control group’s. There is a discrepancy between our findings and the literature’s and it seems that the evaluations on the basis of the factors responsible in the genesis of myomas, the patient complaints, pelvic examinations, age, fertility desire, social status are to be reviewed for each case.

Keywords:

Leimyomas, demografic factors, surgery,

PDF

___

Benagiano G, Kivinen ST, Fadini R, Cronjé H, Klintorp S, van der Spuy ZM. Zoladex (goserelin acetate) and the anemic patient: results of a multicenter fibroid study. Fertil Steril. 1996;66(2):223-229.
Vollenhoven BJ, Lawrence AS, Healy DL. Uterine fibroids: a clinical review. Br J Obstet Gynaecol. 1990 ;97(4):285-298. doi:10.1111/j.1471-0528.1990.tb01804.x
Hillis SD, Marchbanks PA, Peterson HB. Uterine size and risk of complications among women undergoing abdominal hysterectomy for leiomyomas. Obstet Gynecol. 1996;87(4):539-543. doi:10.1016/0029-7844(95)00478-5
Vikhlyaeva EM, Khodzhaeva ZS, Fantschenko ND. Familial predisposition to uterine leiomyomas. Int J Gynaecol Obstet. 1995;51(2):127-131. doi:10.1016/0020-7292(95)02533-i Lumbiganon P, Rugpao S, Phandhu-fung S, Laopaiboon M, Vudhikamraksa N, Werawatakul Y. Protective effect of depot-medroxyprogesterone acetate on surgically treated uterine leiomyomas: a multicentre case--control study. Br J Obstet Gynaecol. 1996;103(9):909-914. doi:10.1111/j.1471-0528.1996.tb09911.x
Wallach EE. Myomectomy. In: Thompson JD, Rock JA, eds. Telinde’s Operative Gynecology. 7th ed. Philadelphia: JB Lippincott; 1992:647-662.
Shikora SA, Niloff JM, Bistrian BR, Forse RA, Blackburn GL. Relationship between obesity and uterine leiomyomata. Nutrition. 1991;7(4):251-255.
Tulandi T. Uterin myomas. Clinic of North Am. 1996;7(1):109-181.
Carlson KJ, Miller BA, Fowler FJ Jr. The Maine Women's Health Study: II. Outcomes of nonsurgical management of leiomyomas, abnormal bleeding, and chronic pelvic pain. Obstet Gynecol. 1994;83(4):566-572. doi:10.1097/00006250-199404000-00013
Bradham DD, Stovall TG, Thompson CD. Use of GnRH agonist before hysterectomy: a cost simulation. Obstet Gynecol. 1995;85(3):401-406. doi:10.1016/0029-7844(94)00402-Y
Buttram VC Jr, Reiter RC. Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril. 1981;36(4):433-445. doi:10.1016/s0015-0282(16)45789-4